ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

HHS Secretary Rebukes Task Force Guidelines On Breast Cancer Screening

November 29, 2009

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

NIH reauthorization Bill slates For House Vote;

May 28, 1993

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

February 7, 1992